Alpha Teknova, Inc. (TKNO) Revenue History
Annual and quarterly revenue from 2019 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
TKNO Revenue Growth
Revenue Breakdown (FY 2025)
TKNO's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
TKNO Revenue Analysis (2019–2025)
As of May 8, 2026, Alpha Teknova, Inc. (TKNO) generated trailing twelve-month (TTM) revenue of $41.8 million, reflecting strong growth of +13.1% year-over-year. The most recent quarter (Q1 2026) recorded $11.1 million in revenue, up 10.9% sequentially.
Looking at the longer-term picture, TKNO's 5-year compound annual growth rate (CAGR) stands at +5.3%, indicating steady revenue expansion. The company achieved its highest annual revenue of $41.4 million in 2022.
Revenue diversification analysis shows TKNO's business is primarily driven by Lab Essentials (77%), Clinical Solutions (19%), and Other Product (5%). With over half of revenue concentrated in Lab Essentials, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including AZTA (+1.8% YoY), BRKR (+0.4% YoY), and NTRA (+35.9% YoY), TKNO has underperformed the peer group in terms of revenue growth. Compare TKNO vs AZTA →
TKNO Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| TKNOCurrent | $42M | +13.1% | +5.3% | -41.9% | |
 AZTA | $594M | +1.8% | +8.9% | -1.9% | |
 BRKR | $3.4B | +0.4% | +11.6% | 6.9% | |
 NTRA | $2.3B | +35.9% | +42.6% | -13.4% | |
 PACB | $160M | +3.9% | +15.2% | -348.5% | |
 FLGT | $323M | +13.8% | -5.2% | -28.2% |
TKNO Historical Revenue Data (2019–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $40.5M | +7.4% | $13.4M | 33.2% | $-16,976,000 | -41.9% |
| 2024 | $37.7M | +2.9% | $7.2M | 19.2% | $-26,146,000 | -69.3% |
| 2023 | $36.7M | -11.4% | $10.3M | 28.1% | $-35,563,000 | -96.9% |
| 2022 | $41.4M | +12.3% | $17.5M | 42.2% | $-49,659,000 | -119.9% |
| 2021 | $36.9M | +17.9% | $17.6M | 47.8% | $-12,008,000 | -32.5% |
| 2020 | $31.3M | +55.8% | $17.8M | 56.7% | $4.7M | 14.9% |
| 2019 | $20.1M | - | $8.6M | 42.7% | $-1,856,000 | -9.2% |
See TKNO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TKNO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TKNO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonTKNO — Frequently Asked Questions
Quick answers to the most common questions about buying TKNO stock.
Is TKNO's revenue growth accelerating or slowing?
TKNO maintains +13.1% revenue growth, in line with its 5-year CAGR of +5.3%. TTM revenue stands at $42M. Growth rate remains consistent with historical average.
What is TKNO's long-term revenue growth rate?
Alpha Teknova, Inc.'s 5-year revenue CAGR of +5.3% reflects the sustained expansion pattern. Current YoY growth of +13.1% is near this long-term average.
How is TKNO's revenue distributed by segment?
TKNO reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2019-2025 are available for download. Segment mix reveals concentration and diversification trends.